Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation

被引:39
作者
Chen, Hao [1 ]
Nie, Tong [1 ]
Zhang, Penglu [1 ]
Ma, Jun [1 ,2 ]
Shan, Anshan [3 ]
机构
[1] Northeast Agr Univ, Coll Vet Med, Harbin 150030, Heilongjiang, Peoples R China
[2] Northeast Agr Univ, Coll Vet Med, Key Lab Prov Educ Dept Heilongjiang Common Anim D, Harbin, Heilongjiang, Peoples R China
[3] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin 150030, Heilongjiang, Peoples R China
关键词
Hesperidin; Nonalcoholic fatty liver disease; Lipid accumulation; LIVER-DISEASE; PATHOGENESIS; ASSOCIATION; CHOLESTEROL; LIPOGENESIS; MANAGEMENT; SILYMARIN; DIAGNOSIS; PREVENTS; CELLS;
D O I
10.1016/j.lfs.2022.120428
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: In recent years, more and more people are suffering from lifestyle-related disease such as nonalcoholic fatty liver disease (NAFLD) because of unhealthy diet and lack of physical exercise. Hesperidin (HDN) is a flavonoid found in high concentrations in citrus fruits. In this study, we investigated the effect of HDN on NAFLD, providing information to develop dietary supplements for NAFLD treatment and prevention. Materials and methods: Testing kits, hematoxylin-eosin staining, oil red O staining, western blot, immunofluorescence, cck-8 assay, and blood biochemical analysis were carried out during the experiments in vivo and in vitro. Key findings: The current study revealed that HDN significantly reduced liver index and serum lipid levels, and protected against liver steatosis and injury induced by HFD. In addition, HDN suppressed oil acid induced intracellular lipid accumulation in HepG2 cells. Moreover, HDN increased the expression level of pAMPK and downregulated SREBP-1C, ACC and FAS expression in vivo and in vitro. Significance: In summary, HDN attenuates lipid accumulation in vivo and in vitro via AMPK activation, suggesting that HDN may serve as a potential therapeutic agent for treating NAFLD.
引用
收藏
页数:9
相关论文
共 39 条
  • [1] Aller R, 2015, EUR REV MED PHARMACO, V19, P3118
  • [2] Optimal Low-Density Lipoprotein Cholesterol for Cardiovascular Prevention: How Low Should We Go?
    Anderson, Todd J.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (03) : 405 - 408
  • [3] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [4] The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
    Buzzetti, Elena
    Pinzani, Massimo
    Tsochatzis, Emmanuel A.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1038 - 1048
  • [5] Silymarin in non alcoholic fatty liver disease
    Cacciapuoti, Fulvio
    Scognamiglio, Anna
    Palumbo, Rossella
    Forte, Raffaele
    Cacciapuoti, Federico
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2013, 5 (03) : 109 - 113
  • [6] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) : 811 - 826
  • [7] Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
    Chang, Xinxia
    Wang, Zhe
    Zhang, Jinlan
    Yan, Hongmei
    Bian, Hua
    Xia, Mingfeng
    Lin, Huandong
    Jiang, Jiandong
    Gao, Xin
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [8] Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels
    Dahlhoff, Christoph
    Worsch, Stefanie
    Sailer, Manuela
    Hummel, Bjoern A.
    Fiamoncini, Jarlei
    Uebel, Kirsten
    Obeid, Rima
    Scherling, Christian
    Geisel, Juergen
    Bader, Bernhard L.
    Daniel, Hannelore
    [J]. MOLECULAR METABOLISM, 2014, 3 (05): : 565 - 580
  • [9] Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
    Donnelly, KL
    Smith, CI
    Schwarzenberg, SJ
    Jessurun, J
    Boldt, MD
    Parks, EJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (05) : 1343 - 1351
  • [10] Han H, 2021, FOOD FUNCT, V12, P2171, DOI [10.1039/d0fo02623a, 10.1039/D0FO02623A]